GSK plc (GSK) Financials

GSK Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 75.2 billion 58.9 billion
2023-09-30 74.2 billion 58.8 billion
2023-06-30 75.1 billion 59.7 billion
2023-03-31 72.6 billion 58.6 billion

GSK Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 2.8 billion -3.0 billion
2023-09-30 2.1 billion ?
2023-06-30 974.6 million ?
2023-03-31 -589.8 million ?

GSK Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 445.9 million
2023-09-30 1.9 billion
2023-06-30 2.2 billion
2023-03-31 2.0 billion

GSK Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 6.6 billion - 1.5 billion
2023-09-30 8.2 billion 19.5 billion -
2023-06-30 8.2 billion 19.6 billion -
2023-03-31 8.6 billion 20.6 billion -

GSK Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 5.2 billion
2023-09-30 2.5 billion
2023-06-30 3.2 billion
2023-03-31 2.5 billion

GSK Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 997.5 million 2.6 billion 3.4 billion 82.8 million
2023-09-30 606.2 million 1.9 billion 2.8 billion -
2023-06-30 675.4 million 1.7 billion 2.9 billion -
2023-03-31 655.4 million 1.6 billion 2.7 billion -

GSK Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 10.3 billion 3.0 billion
2023-09-30 9.9 billion 2.8 billion
2023-06-30 9.1 billion 2.4 billion
2023-03-31 8.6 billion 2.4 billion

GSK

Price: $43.50

52 week price:
33.33
43.84

Dividend Yield: 0.01%

5-year range yield:
0.01%
5.87%

Forward Dividend Yield: 3.73%

Payout Ratio: 54.15%

Payout Ratio Range:
12.49%
215.10%

Dividend Per Share: 1.62 USD

Earnings Per Share: 2.73 USD

P/E Ratio: 13.80

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 3.7 million

Ebitda: 2.0 billion

Market Capitalization: 88.7 billion

Average Dividend Frequency: 3

Years Paying Dividends: 41

DGR3: -10.18%

DGR5: -7.21%

DGR10: -3.71%

DGR20: 1.60%

Links: